USPTO trademark

EMTIMRY

Under examinationUSPTOWord markClass 5

"EMTIMRY" is a word mark owned by Teva Pharmaceutical Industries Ltd., filed at the USPTO on September 9, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Teva Pharmaceutical Industries Ltd. portfolioGet this data via the API
Official USPTO record
EMTIMRY trademark as filed
As filed with the USPTO
Status
Under examination
Since September 30, 2026
Filed
September 9, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50098372
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns EMTIMRY

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Teva Pharmaceutical Industries Ltd.

Tel Aviv, Israel

1,141 trademarks in the portfolioView company

Representative

Lori Wolfe

Teva Pharmaceuticals USA, Inc.

Goods and services

What the mark covers

The products and services EMTIMRY is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of non-final action e-mailed
  2. Non-final action e-mailed
  3. Non-final action written
  4. Assigned to examiner
  5. New application office supplied data entered
  6. Application filing receipt mailed
  7. New application entered
FAQ

About EMTIMRY

Who owns the trademark "EMTIMRY"?

The USPTO trademark "EMTIMRY" (application 50098372) is owned by Teva Pharmaceutical Industries Ltd.

What is the status of "EMTIMRY"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull EMTIMRY and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a08b77-30b3-7477-bf4d-33ca48078b5f
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a08b77-30b3-7477-bf4d-33ca48078b5f",
  "object": "trademark",
  "mark_text": "EMTIMRY",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50098372",
  "filing_date": "2026-09-09",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Teva Pharmaceutical Industries Ltd.",
      "entity_id": "ent_019ebbc5-6f32-7092-a649-5aaa7b712e21"
    }
  ]
}